LiquiVida Wellness Therapy Franchise For Sale
Liquivida® is the leader in the IV vitamin therapy industry and is fully diversified in its products and services. It serves customer needs ranging from anti-aging, medical aesthetics, and weight loss, along with personal beauty and care.
The US healthcare industry is broken. But we’re partnering with the best in modern medicine to make a difference in our communities and around the world. By focusing on the larger population, we believe we can proactively keep people healthy, so they can live more active and fulfilling lifestyles.
Why LiquVida?
· Proprietary Custom I.V. Drip Technology
· Multiple Revenue Streams: Products & Services
· Comprehensive Training & Ongoing Support
· Program Affiliated with Over 4000 Doctors
· No Medical License Required
· Membership model
· Multiple revenue streams
Restaurants for Sale
Service Businesses for Sale
Wholesale & Distribution Businesses for Sale
Finance & Accounting Businesses for Sale
Furniture & Home Decor Businesses for Sale
Smoke & Vape Shops for Sale
Advertising & Promotional Businesses for Sale
Miscellaneous Businesses for Sale
Retail Businesses for Sale
Digital Marketing Business for Sale
Technology Franchise Opportunities
Printing, Signs & Publishing Franchise Opportunities
Fitness & Wellness Franchises for Sale
Cleaning & Janitorial Franchises for Sale
Healthcare & Medical Franchise Opportunities
Real Estate & Property Management Franchise for Sale
Automotive Franchises for Sale
Coffee, Bakery & Dessert Franchise Opportunities
Transport & Shipping Franchise Opportunities
Environmental Franchise Opportunities
Commercial Spaces for Sale or Lease
Warehouses for Sale or Lease
Miscellaneous Properties for Sale or Lease
Apartment Buildings for Sale
Mixed Use Buildings for Sale or Rent
Medical Office Spaces for Sale or Rent
Office Buildings for Sale or Rent
Medical Buildings for Sale or Lease
Places of Worship for Sale
Retail Buildings for Sale or Lease
An email will be sent to registered email address.
Please select if you are: